Multiple sclerosis.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000032:analysis; D002555:Cerebrospinal Fluid / Q000276:immunology; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000150:complications; D004812:Epidemiologic Methods; D005071:Evoked Potentials; D006168:Guinea Pigs; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007125:Immunogenetics; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications; D009103:Multiple Sclerosis; D009185:Myelin Proteins / Q000378:metabolism; D010276:Parasympatholytics / Q000627:therapeutic use; D010919:Placebos; D011602:Psychophysiologic Disorders / Q000628:therapy; D014777:Virus Diseases / Q000150:complications; D014787:Vision Tests
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D006680:HLA Antigens; D009185:Myelin Proteins; D010276:Parasympatholytics; D010919:Placebos